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ABSTRACT 
Conjugated linoleic acids (CLAs) are group of polyunsaturated fatty acids that attract 
considerable attention due to their anticarcinogenic effects. In this study, the viability, 
apoptosis and cell cycle status of human hepatoma cells (HepG2) following treatment with 
cis-9,trans-11(c9,t11), trans-10,cis-12 (t10,c12) and mixed isomers of CLA were investigated. 
Cells were grown routinely on RPMI 1640 media and treated with different concentrations of 
CLA isomers for 72 hours. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
(MTT) cytotoxicity assay, acridine orange/propidium iodide (AO/PI) staining and terminal 
deoxynucleotide transferase deoxyuridine triphosphate nick end labeling (TUNEL) assay 
were used to determine the results. The viability of HepG2 cells was reduced significantly (P 
< 0.05) by all CLA isomers tested in a dose-dependent manner. The median inhibitory 
concentration (IC50) value varies with type of CLA isomer. Mixed isomers were 
significantly (P < 0.05) more potent than c9, t11 CLA isomer. All CLA isomers tested were 
able to induce characteristic apoptotic changes and significant (P < 0.05) proportion of 
apoptosis. Significantly (P < 0.05) higher proportion of cells in G0/1 and lower proportion in 
G2/M phases of the cell cycle in treated cells were also observed. Therefore, results 
suggested that CLA isomers reduce viability and proliferation of HepG2 cancer cells in 
relation with cell cycle arrest and induction of apoptosis.  
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